HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mikihiro Kohno Selected Research

Adenocarcinoma

2/2022Consideration of the Optimal Surgical Procedure Based on the Risk of Recurrence in Clinical Stage 0 or IA Lung Adenocarcinoma.
12/2016Molecular Factors Associated with Pemetrexed Sensitivity According to Histological Type in Non-small Cell Lung Cancer.
3/2015Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer.
12/2013Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mikihiro Kohno Research Topics

Disease

21Neoplasms (Cancer)
03/2024 - 02/2013
11Adenocarcinoma of Lung
04/2024 - 07/2014
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 01/2014
8Lung Neoplasms (Lung Cancer)
01/2024 - 03/2012
5Mesothelioma
01/2021 - 01/2018
4Adenocarcinoma
02/2022 - 12/2013
3Malignant Mesothelioma
01/2021 - 02/2013
3Neoplasm Metastasis (Metastasis)
01/2021 - 12/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2023 - 12/2016
2Disease Progression
11/2021 - 04/2012
2Carcinoma (Carcinomatosis)
12/2016 - 12/2013
2Lymphoma (Lymphomas)
08/2015 - 03/2015
1Interstitial Lung Diseases (Interstitial Lung Disease)
05/2024
1Sleep Initiation and Maintenance Disorders (Insomnia)
05/2024
1Rupture
05/2024
1Fistula
01/2024
1Pneumothorax
01/2024
1Chronic Obstructive Pulmonary Disease (COPD)
11/2023
1Necrosis
02/2023
1Sarcopenia
02/2023
1Inflammation (Inflammations)
01/2023
1Abscess
10/2022
1Tuberculosis (Tuberculoses)
10/2022
1Lung Diseases (Lung Disease)
01/2022
1Pulmonary Edema
10/2015
1Residual Neoplasm
05/2014
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2014
1Hepatocellular Carcinoma (Hepatoma)
04/2013

Drug/Important Bio-Agent (IBA)

6Messenger RNA (mRNA)IBA
03/2024 - 12/2013
6Proteins (Proteins, Gene)FDA Link
12/2023 - 12/2013
3Granzymes (Granzyme)IBA
12/2023 - 11/2020
3ErbB Receptors (EGF Receptor)IBA
11/2021 - 03/2015
3Tyrosine Kinase InhibitorsIBA
11/2021 - 07/2014
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 05/2014
2Glutathione PeroxidaseIBA
04/2024 - 03/2024
2AntioxidantsIBA
03/2024 - 03/2012
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2023 - 01/2022
2C-Reactive ProteinIBA
06/2023 - 06/2023
2B7-H1 AntigenIBA
01/2022 - 01/2016
2Brachyury protein (Brachyury)IBA
12/2016 - 12/2013
2Phosphotransferases (Kinase)IBA
08/2015 - 03/2015
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
08/2015 - 03/2015
2AsbestosIBA
01/2014 - 02/2013
1lemborexantIBA
05/2024
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
05/2024
1Prostaglandins AIBA
05/2024
1EnzymesIBA
03/2024
1osimertinibIBA
01/2024
1Serine Proteases (Serine Protease)IBA
11/2023
1TransducinIBA
11/2023
1GoldIBA
11/2023
1Anti-Bacterial Agents (Antibiotics)IBA
02/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Antitubercular AgentsIBA
10/2022
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2022
1Carcinoembryonic AntigenIBA
01/2022
1Gefitinib (Iressa)FDA Link
11/2021
1GlucocorticoidsIBA
01/2021
1Neutralizing AntibodiesIBA
01/2021
1Interleukin-15 (Interleukin 15)IBA
01/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
11/2020
1hydrogen sulfite (bisulfite)IBA
10/2020
1Succinate Dehydrogenase (Fumarate Reductase)IBA
12/2016
1Pemetrexed (MTA)FDA Link
12/2016
1Programmed Cell Death 1 ReceptorIBA
01/2016
1Monoclonal AntibodiesIBA
01/2016
1Cytotoxins (Cytolysins)IBA
03/2015
1Fluorouracil (Carac)FDA LinkGeneric
03/2015
1Hormones (Hormone)IBA
07/2014
1Aromatase (CYP19)IBA
07/2014
1Aromatase InhibitorsIBA
07/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2014
1exemestane (Aromasin)FDA Link
07/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
05/2014
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
05/2014
1Etoposide (VP 16)FDA LinkGeneric
05/2014
1Cadherins (E-Cadherin)IBA
12/2013
1Interleukin-8 (Interleukin 8)IBA
12/2013
1Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA
04/2013
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2013
1Epidermal Growth Factor (EGF)IBA
12/2012
1Anaplastic Lymphoma KinaseIBA
12/2012

Therapy/Procedure

10Therapeutics
02/2023 - 10/2015
3Radiotherapy
01/2021 - 01/2018
2Drug Therapy (Chemotherapy)
01/2024 - 01/2018
2Neoadjuvant Therapy
02/2023 - 05/2014
2Operative Surgical Procedures
02/2022 - 07/2015
2Aftercare (After-Treatment)
11/2021 - 04/2012
2Pneumonectomy (Lung Volume Reduction)
01/2020 - 02/2013
1Mechanical Ventilators (Ventilator)
05/2024
1Thoracotomy
01/2024
1Chest Tubes (Chest Tube)
01/2024
1Conservative Treatment
02/2023
1Segmental Mastectomy (Lumpectomy)
02/2023
1Lung Transplantation
01/2022
1Combined Modality Therapy
01/2021
1Continuous Positive Airway Pressure
10/2015
1Induction Chemotherapy
05/2014
1Extracorporeal Circulation
05/2014